Chapin Davis Inc. Has $253,000 Position in Colgate-Palmolive (NYSE:CL)

Chapin Davis Inc. raised its holdings in shares of Colgate-Palmolive (NYSE:CL) by 8.3% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,611 shares of the company’s stock after acquiring an additional 200 shares during the quarter. Chapin Davis Inc.’s holdings in Colgate-Palmolive were worth $253,000 at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in the stock. Union Savings Bank boosted its holdings in Colgate-Palmolive by 76.6% in the fourth quarter. Union Savings Bank now owns 309 shares of the company’s stock worth $25,000 after purchasing an additional 134 shares in the last quarter. E Fund Management Hong Kong Co. Ltd. acquired a new stake in shares of Colgate-Palmolive in the second quarter worth $25,000. Atlantic Edge Private Wealth Management LLC bought a new stake in shares of Colgate-Palmolive during the 4th quarter worth $32,000. PSI Advisors LLC boosted its holdings in Colgate-Palmolive by 4,971.4% during the first quarter. PSI Advisors LLC now owns 355 shares of the company’s stock valued at $32,000 after acquiring an additional 348 shares during the period. Finally, Core Wealth Advisors Inc. increased its stake in shares of Colgate-Palmolive by 56.6% in the fourth quarter. Core Wealth Advisors Inc. now owns 404 shares of the company’s stock worth $32,000 after purchasing an additional 146 shares during the period. 80.41% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research analysts recently issued reports on the stock. Stifel Nicolaus increased their price target on shares of Colgate-Palmolive from $95.00 to $105.00 and gave the stock a “buy” rating in a research report on Monday, July 22nd. Argus upped their target price on shares of Colgate-Palmolive from $97.00 to $107.00 and gave the stock a “buy” rating in a research report on Wednesday, May 15th. Sanford C. Bernstein upped their target price on shares of Colgate-Palmolive from $100.00 to $103.00 and gave the company a “market perform” rating in a research report on Tuesday, July 30th. Bank of America increased their price target on Colgate-Palmolive from $100.00 to $110.00 and gave the company a “buy” rating in a research note on Wednesday, July 10th. Finally, HSBC reaffirmed a “hold” rating on shares of Colgate-Palmolive in a research note on Friday, July 26th. Eight analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. According to data from MarketBeat, Colgate-Palmolive presently has a consensus rating of “Moderate Buy” and an average target price of $101.11.

Insider Buying and Selling at Colgate-Palmolive

In other news, insider Sally Massey sold 15,850 shares of the firm’s stock in a transaction dated Tuesday, August 6th. The shares were sold at an average price of $103.28, for a total transaction of $1,636,988.00. Following the sale, the insider now owns 13,942 shares of the company’s stock, valued at approximately $1,439,929.76. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other news, insider Sally Massey sold 15,850 shares of the business’s stock in a transaction on Tuesday, August 6th. The shares were sold at an average price of $103.28, for a total value of $1,636,988.00. Following the transaction, the insider now owns 13,942 shares of the company’s stock, valued at $1,439,929.76. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, insider Panagiotis Tsourapas sold 14,794 shares of the firm’s stock in a transaction that occurred on Thursday, August 8th. The shares were sold at an average price of $102.94, for a total value of $1,522,894.36. Following the completion of the sale, the insider now directly owns 5,146 shares of the company’s stock, valued at $529,729.24. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 41,177 shares of company stock worth $4,245,835. 0.34% of the stock is currently owned by company insiders.

Colgate-Palmolive Trading Up 0.5 %

NYSE:CL traded up $0.55 during trading hours on Friday, hitting $101.99. 3,172,690 shares of the company were exchanged, compared to its average volume of 4,407,037. Colgate-Palmolive has a one year low of $67.62 and a one year high of $104.15. The company has a current ratio of 1.06, a quick ratio of 0.28 and a debt-to-equity ratio of 16.90. The company has a fifty day simple moving average of $98.29 and a 200 day simple moving average of $92.30. The stock has a market capitalization of $83.68 billion, a price-to-earnings ratio of 32.28, a price-to-earnings-growth ratio of 3.54 and a beta of 0.39.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, July 26th. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.87 by $0.04. Colgate-Palmolive had a net margin of 14.21% and a return on equity of 470.19%. The firm had revenue of $5.06 billion during the quarter, compared to analysts’ expectations of $5 billion. During the same period last year, the company earned $0.77 earnings per share. The business’s revenue was up 4.9% on a year-over-year basis. Sell-side analysts expect that Colgate-Palmolive will post 3.57 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, August 15th. Stockholders of record on Friday, July 19th were paid a dividend of $0.50 per share. The ex-dividend date of this dividend was Friday, July 19th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.96%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 63.29%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.